🔎 Trials Near Me

Utama › Kanser (semua jenis) › Utah › Salt Lake City

Kajian klinikal Kanser (semua jenis) di Salt Lake City, UT

27 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Salt Lake City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
1 Month – 17 Years · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07630974

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

Mengambil peserta
  • Huntsman Cancer Institute/ University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07410689

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Mengambil pesertaFasa 3
  • Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06901531

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Mengambil pesertaFasa 2
  • Intermountain Healthcare, Salt Lake City
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Mengambil pesertaFasa 2/3
  • University of Utah - Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare - LDS Hospital, Salt Lake City
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
1 Month – 17 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06941272

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Mengambil pesertaFasa 2
  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04996875

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Mengambil pesertaFasa 1/2
  • Huntsman Cancer Institute /ID# 271618, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06953960

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Mengambil pesertaFasa 1/2
  • Huntsman Cancer Institute, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06634589

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Primary Children's Hospital, Salt Lake City
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Mengambil pesertaFasa 3
  • University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05335928

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Mengambil pesertaFasa 3
  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06657144

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Mengambil peserta
  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jul 2026 · NCT07556380

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Mengambil peserta
  • VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Jun 2026 · NCT05486572

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Mengambil peserta
  • University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
  • University of Utah Primary Children's Hospital, Salt Lake City
Umur 15 hingga 29 · Semua jantina · Dikemas kini 22 Mei 2026 · NCT05958316

Galleri® in the Medicare Population.

Mengambil pesertaSukarelawan sihat dialu-alukan
  • HCA Healthcare St. Marks, Salt Lake City
Umur 50 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT05673018

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Mengambil pesertaFasa 2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT01042379

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Mengambil peserta
  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Apr 2026 · NCT05297734

Improving Health Insurance Literacy Among Young Adult Cancer Survivors

Mengambil peserta
  • University of Utah, Salt Lake City
Umur 26 hingga 45 · Semua jantina · Dikemas kini 28 Apr 2026 · NCT05829070

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Mengambil pesertaFasa 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT03328078

Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type

Mengambil peserta
  • Huntsman Cancer Institute, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Nov 2025 · NCT06484179

Childhood Cancer Predisposition Study (CCPS)

Mengambil pesertaKajian pemerhatian
  • Primary Children's Hospital, Salt Lake City
Semua umur · Semua jantina · Dikemas kini 29 Okt 2025 · NCT04511806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Salt Lake City
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Mengambil pesertaKajian pemerhatian
  • Utah Cancer Specialists, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2025 · NCT05234177

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Mengambil peserta
  • Huntsman Cancer Institute (The University of Utah), Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Nov 2024 · NCT03860883

Kajian Kanser (semua jenis) di bandar lain

Kajian lain di Salt Lake City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.